Company Data
Tempest Therapeutics Inc.
Ticker
TPST
Current Price
$1.01 33.7%
Market Cap
$16.7M
Price Target
Refer to Report
Volume
56.1M
52wk Range
$0.7432 - $12.23
Overview
Tempest Therapeutics Inc is a clinical-stage biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity.